European Journal of Internal Medicine
Volume 19, Issue 1 , Pages 57-59 , January 2008

Cardiomyopathy in Pompe's disease

Received 26 July 2007 ,Accepted 26 September 2007.

References 

  1. Bodamer OA, Leonard JV, Halliday D. Dietary treatment in late-onset acid maltase deficiency. Eur J Pediatr. Aug 1997;156(Suppl 1):S39–S42
  2. Hirschhorn R, Reuser AJJ. Glycogen storage disease type II: acid α-glucosidase (acid maltase) deficiency. In:  Scriver CR,  Beaudet A,  Sly WS,  Valle D editor. The metabolic and molecular bases of inherited disease. vol. III:New York, NY: McGraw-Hill; 2001;p. 3389–3420
  3. Hug G, Soukup S, Ryan M, Chuck G. Rapid prenatal diagnosis of glycogen-storage disease type II by electron microscopy of uncultured amniotic-fluid cells. N Engl J Med. Apr 19 1984;310(16):1018–1022
  4. Cornelio F, Di Donato S. Myopathies due to enzyme deficiencies. J Neurol. 1985;232(6):329–340
  5. Finsterer J, Stollberger C. The heart in human dystrophinopathies. Cardiology. 2003;99(1):1–19
  6. Ben-Ami R, Puglisi J, Haider T, Mehta D. The Mount Sinai Hospital clinical pathological conference: a 45-year-old man with Pompe's disease and dilated cardiomyopathy. Mt Sinai J Med. May 2001;68(3):205–212
  7. Caddell JL. Metabolic and nutritional disease. In:  Adams FH,  Emmanouilides GC,  Riemenschneider TA editor. Heart disease in infants, children, and adolescents. 4th ed.. Baltimore: willians e Wilkins; 1989;p. 753–755
  8. Van Maldergem L, Haumont D, Saurty D, Jauniaux E, Loeb H. Bradycardia in a case of type II glycogenosis (Pompe's disease) revealing in early neonatal period. Acta Clin Belg. 1990;45(6):412–414
  9. Gussenhoven WJ, Busch HF, Kleijer WJ, de Villeneuve VH. Echocardiographic features in the cardiac type of glycogen storage disease II. Eur Heart J. Jan 1983;4(1):41–43
  10. Nagueh SF, Bachinski LL, Meyer D, et al. Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation. 2001;104:128–130
  11. Van den Hout HM, Hop W, van Diggelen OP, Smeitink JA, Smit GP, Poll-The BT, et al. The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. Pediatrics. Aug 2003;112(2):332–340
  12. Engel AG, Hirschorn R. Acid maltase deficiency. In:  Engel AG, Franzini-Armstrong  editor. Myology. ed 2. New York: Mc Graw Hill; 1994;p. 1533–1553
  13. Akamatsu A, Nomoto R, Nagao H, Murakami H, Nonaka I, Tara M, et al. Adult form acid maltase deficiency—a case report. Jpn J Med. Jul 1982;21(3):203–209
  14. Rees A, Elbl F, Minhas K, Solinger R. Echocardiographic evidence of outflow tract obstruction in Pompe's disease (glycogen storage disease of the heart). Am J Cardiol. Jun 1976;37(7):1103–1106
  15. Stollberger C, Finsterer J. Echocardiography in storage and neuromuscular disorders.. Wien Klin Wochenschr. Jun 15 2001;113(11–12):408–415
  16. Bulkley BH, Hutchins GM. Pompe's disease presenting as hypertrophic myocardiopathy with Wolff–Parkinson–White syndrome. Am Heart J. Aug 1978;96(2):246–252
  17. Marwick TH. Techniques for comprehensive two dimensional echocardiographic assessment of left ventricular systolic function. Heart. Nov 2003;89(Suppl 3):iii2–iii8
  18. Urheim S, Edvardsen T, Torp H, Angelsen B, Smiseth OA. Myocardial strain by Doppler echocardiography: validation of a new method to quantify regional myocardial function. Circulation. 2000;102:1158–1164

PII: S0953-6205(07)00254-3

doi: 10.1016/j.ejim.2007.09.018

European Journal of Internal Medicine
Volume 19, Issue 1 , Pages 57-59 , January 2008

Article Tools

* Image Usage & Resolution